RxDoctor Payments DataLook up a doctor →

VONVENDI: payments to doctors

Payments that named VONVENDI as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$34.5M
Providers
615
Transactions
911
Average per transaction
$37,842

The per-transaction average — $37,842 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 615 providers the average total is $56,056, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Takeda Pharmaceuticals U.S.A., Inc.$31,351,62890.9%
Shire North American Group Inc$3,122,7699.1%
← All drugs & devices